UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Clinical Pharmacokinetic, Pharmacodynamic and Drug-Interaction Profile of the Integrase Inhibitor Dolutegravir

Clinical pharmacokinetics, 2013-11, Vol.52 (11), p.981-994

2013

Link zum Volltext

Verfügbarkeit prüfen

Ultra-long-acting tunable biodegradable and removable controlled release implants for drug delivery

Nature communications, 2019-09, Vol.10 (1), p.4324-12, Article 4324

2019

Link zum Volltext

Verfügbarkeit prüfen

Pharmacology of HIV Cure: Site of Action

Clinical pharmacology and therapeutics, 2021-04, Vol.109 (4), p.841-855

2021

Link zum Volltext

Verfügbarkeit prüfen

A Translational Pharmacology Approach to Predicting Outcomes of Preexposure Prophylaxis Against HIV in Men and Women Using Tenofovir Disoproxil Fumarate With or Without Emtricitabine

The Journal of infectious diseases, 2016-07, Vol.214 (1), p.55-64

2016

Link zum Volltext

Verfügbarkeit prüfen

Biodegradable polymeric solid implants for ultra-long-acting delivery of single or multiple antiretroviral drugs

International journal of pharmaceutics, 2021-08, Vol.605, p.120844-120844, Article 120844

2021

Link zum Volltext

Verfügbarkeit prüfen

Low daily oral PrEP adherence and low validity of self-report in a randomized trial among PWID in Ukraine

The International journal of drug policy, 2024-01, Vol.123, p.104284-104284, Article 104284

2024

Link zum Volltext

Verfügbarkeit prüfen

Long-acting biodegradable implant for sustained delivery of antiretrovirals (ARVs) and hormones

Journal of controlled release, 2021-12, Vol.340, p.188-199

2021

Link zum Volltext

Verfügbarkeit prüfen

A multicompartment population PK model to predict tenofovir and emtricitabine mucosal tissue concentrations for HIV prevention

CPT: pharmacometrics and systems pharmacology, 2023-12, Vol.12 (12), p.1922-1930

2023

Link zum Volltext

Verfügbarkeit prüfen

Reservoir-Style Polymeric Drug Delivery Systems: Empirical and Predictive Models for Implant Design

Pharmaceuticals (Basel, Switzerland), 2022-10, Vol.15 (10), p.1226

2022

Link zum Volltext

Verfügbarkeit prüfen

Deep analysis of CD4 T cells in the rhesus CNS during SIV infection

PLoS pathogens, 2023-12, Vol.19 (12), p.e1011844-e1011844

2023

Link zum Volltext

Verfügbarkeit prüfen

Validation of an LC-MS/MS assay for the simultaneous determination of bictegravir, doravirine, and raltegravir in human plasma

Journal of pharmaceutical and biomedical analysis, 2022-10, Vol.220, p.115010-115010, Article 115010

2022

Link zum Volltext

Verfügbarkeit prüfen

Ultra-long-acting in-situ forming implants with cabotegravir protect female macaques against rectal SHIV infection

Nature communications, 2023-02, Vol.14 (1), p.708-708, Article 708

2023

Link zum Volltext

Verfügbarkeit prüfen

Author Correction: Ultra-long-acting in-situ forming implants with cabotegravir protect female macaques against rectal SHIV infection

Nature communications, 2024-02, Vol.15 (1), p.1054-1054, Article 1054

2024

Link zum Volltext

Verfügbarkeit prüfen

Distinct mechanisms of long-term virologic control in two HIV-infected individuals after treatment interruption of anti-retroviral therapy

Nature medicine, 2021-11, Vol.27 (11), p.1893

2021

Link zum Volltext

Verfügbarkeit prüfen

Intracellular islatravir pharmacology differs between species in an in vitro model: implications for preclinical study design

Journal of antimicrobial chemotherapy, 2022-03, Vol.77 (4), p.1000-1004

2022

Link zum Volltext

Verfügbarkeit prüfen

Pharmacology of Antiretrovirals in the Female Genital Tract for HIV Prevention

Journal of clinical pharmacology, 2018-11, Vol.58 (11), p.1381-1395

2018

Link zum Volltext

Verfügbarkeit prüfen

Decreased Tenofovir Diphosphate Concentrations in a Transgender Female Cohort: Implications for Human Immunodeficiency Virus Preexposure Prophylaxis

Clinical infectious diseases, 2019-11, Vol.69 (12), p.2201-2204

2019

Link zum Volltext

Verfügbarkeit prüfen

Genital Inflammation Is Not Associated With Decreased Vaginal Tenofovir Concentrations in Women Taking Oral PrEP

Journal of acquired immune deficiency syndromes (1999), 2022-04, Vol.89 (4), p.390

2022

Link zum Volltext

Verfügbarkeit prüfen

Long-acting injectable multipurpose prevention technology for prevention of HIV and unplanned pregnancy

Journal of controlled release, 2023-11, Vol.363, p.606-620

2023

Link zum Volltext

Verfügbarkeit prüfen

Vaginal microbiome, antiretroviral concentrations, and HIV genital shedding in the setting of hormonal contraception initiation in Malawi

AIDS (London), 2023-11, Vol.37 (14), p.2185

2023

Link zum Volltext

Verfügbarkeit prüfen

Validation of an LC–MS/MS assay to simultaneously monitor the intracellular active metabolites of tenofovir, emtricitabine, and lamivudine in dried blood spots

Journal of pharmaceutical and biomedical analysis, 2018-02, Vol.149, p.40-45

2018

Link zum Volltext

Verfügbarkeit prüfen

Single-dose pharmacokinetics of tenofovir alafenamide and its active metabolite in the mucosal tissues

Journal of antimicrobial chemotherapy, 2017-06, Vol.72 (6), p.1731-1740

2017

Link zum Volltext

Verfügbarkeit prüfen

Next generation 3D-printed intravaginal ring for prevention of HIV and unintended pregnancy

Biomaterials, 2023-10, Vol.301, p.122260-122260, Article 122260

2023

Link zum Volltext

Verfügbarkeit prüfen

Seminal Tenofovir Concentrations, Viral Suppression, and Semen Quality With Tenofovir Alafenamide, Compared With Tenofovir Disoproxil Fumarate (Spanish HIV/AIDS Research Network, PreEC/RIS 40)

Clinical infectious diseases, 2019-09, Vol.69 (8), p.1403-1409

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 81

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(67)

Publikationsform

Artikel
(80)
Buchkapitel
(1)

Sprache

Englisch
(81)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(63)
Life Sciences & Biomedicine
(59)
Humans
(46)
Hiv Infections - Drug Therapy
(34)
Female
(30)
Hiv
(30)
Pharmacology & Pharmacy
(29)
Infectious Diseases
(24)
Human Immunodeficiency Virus
(23)
Immunology
(17)
Hiv Infections - Prevention & Control
(16)
Adult
(14)
Anti-Hiv Agents - Therapeutic Use
(14)
Animals
(13)
Anti-Hiv Agents - Pharmacokinetics
(12)
Antiretroviral Drugs
(12)
Pharmacokinetics
(12)
Tenofovir
(12)
Antiretroviral Therapy
(11)
Emtricitabine
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Clinical Pharmacokinetic, Pharmacodynamic and Drug-Interaction Profile of the Integrase Inhibitor Dolutegravir

Ultra-long-acting tunable biodegradable and removable controlled release implants for drug delivery

Pharmacology of HIV Cure: Site of Action

A Translational Pharmacology Approach to Predicting Outcomes of Preexposure Prophylaxis Against HIV in Men and Women Using Tenofovir Disoproxil Fumarate With or Without Emtricitabine

Biodegradable polymeric solid implants for ultra-long-acting delivery of single or multiple antiretroviral drugs

Low daily oral PrEP adherence and low validity of self-report in a randomized trial among PWID in Ukraine

Long-acting biodegradable implant for sustained delivery of antiretrovirals (ARVs) and hormones

A multicompartment population PK model to predict tenofovir and emtricitabine mucosal tissue concentrations for HIV prevention

Reservoir-Style Polymeric Drug Delivery Systems: Empirical and Predictive Models for Implant Design

Deep analysis of CD4 T cells in the rhesus CNS during SIV infection

Validation of an LC-MS/MS assay for the simultaneous determination of bictegravir, doravirine, and raltegravir in human plasma

Ultra-long-acting in-situ forming implants with cabotegravir protect female macaques against rectal SHIV infection

Author Correction: Ultra-long-acting in-situ forming implants with cabotegravir protect female macaques against rectal SHIV infection

Distinct mechanisms of long-term virologic control in two HIV-infected individuals after treatment interruption of anti-retroviral therapy

Intracellular islatravir pharmacology differs between species in an in vitro model: implications for preclinical study design

Pharmacology of Antiretrovirals in the Female Genital Tract for HIV Prevention

Decreased Tenofovir Diphosphate Concentrations in a Transgender Female Cohort: Implications for Human Immunodeficiency Virus Preexposure Prophylaxis

Genital Inflammation Is Not Associated With Decreased Vaginal Tenofovir Concentrations in Women Taking Oral PrEP

Long-acting injectable multipurpose prevention technology for prevention of HIV and unplanned pregnancy

Vaginal microbiome, antiretroviral concentrations, and HIV genital shedding in the setting of hormonal contraception initiation in Malawi

Dynamics of the Decay of Human Immunodeficiency Virus (HIV) RNA and Distribution of Bictegravir in the Genital Tract and Rectum in Antiretroviral-naive Adults Living With HIV–1 Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide (Spanish HIV/AIDS Research Network, PreEC/RIS 58)

Validation of an LC–MS/MS assay to simultaneously monitor the intracellular active metabolites of tenofovir, emtricitabine, and lamivudine in dried blood spots

Single-dose pharmacokinetics of tenofovir alafenamide and its active metabolite in the mucosal tissues

Next generation 3D-printed intravaginal ring for prevention of HIV and unintended pregnancy

Seminal Tenofovir Concentrations, Viral Suppression, and Semen Quality With Tenofovir Alafenamide, Compared With Tenofovir Disoproxil Fumarate (Spanish HIV/AIDS Research Network, PreEC/RIS 40)

Suchergebnisse filtern